脑出血患者每小时收缩压变异度与结局的关联具有时间依赖性:ATACH-2 试验事后分析
该研究为 ATACH-2 试验的事后分析,纳入 961 例脑出血患者,平均年龄 62±13 岁,61.9% 为男性,症状发作至入组平均 184±56 分钟。以入组后最初 24 小时每小时收缩压最大值与最小值之差(每小时收缩压范围)计算每小时收缩压变异度,平均 15.6±16 mm Hg,且随随机化后时间间隔延长而显著降低(第 1 小时 41.8±23.3 至第 24 小时 12.4±14.0,P<0.0001)。入组后 5 小时(P=0.014)和 6 小时(P=0.014)的收缩压变异度与 90 天死亡或残疾显著相关;24 小时内神经功能恶化风险与收缩压变异度高度相关,随机化后 1 小时(P<0.001)至 5 小时(P<0.001)关联最大,显著关联持续至随机化后 22 小时;血肿扩大风险与随机化后 3 小时(P=0.015)至 8 小时(P=0.002)的收缩压变异度相关;收缩压变异度与急性肾损伤风险未见统计学显著关联。作者认为随机化后最初 8 小时内收缩压变异度降低似乎对短期和长期结局影响最大,最初 8 小时可能是未来干预的时间窗。
要点
- 脑出血患者入组后最初 24 小时平均每小时收缩压变异度为 15.6±16 mm Hg,且随随机化后时间延长显著降低(第 1 小时 41.8±23.3 至第 24 小时 12.4±14.0,P<0.0001)。
- 入组后 5 小时(P=0.014)和 6 小时(P=0.014)的收缩压变异度与 90 天死亡或残疾(改良 Rankin 量表评分 4-6 分)显著相关,随机化后 8 小时内其余时间点呈正向但未达统计学显著的关联。
- 24 小时内神经功能恶化风险与收缩压变异度高度相关,随机化后 1 小时(P<0.001)至 5 小时(P<0.001)关联最大,显著关联持续至随机化后 22 小时。
- 血肿扩大(24 小时 CT 体积增加>33%)风险与随机化后 3 小时(P=0.015)至 8 小时(P=0.002)的收缩压变异度相关。
- 收缩压变异度与入组后 72 小时内急性肾损伤风险未见统计学显著关联。
适用人群与场景
- ATACH-2 试验纳入的脑出血患者,共 961 例,平均年龄 62±13 岁,61.9% 为男性,症状发作至入组平均 184±56 分钟。
诊断标准与关键阈值
- 每小时收缩压变异度以入组后最初 24 小时每小时收缩压最大值与最小值之差(每小时收缩压范围)计算。
- 死亡或残疾定义为 90 天改良 Rankin 量表评分 4-6 分。
- 血肿扩大定义为 24 小时 CT 扫描血肿体积增加>33%。
红旗征与不能漏的情况
- 24 小时内神经功能恶化风险与收缩压变异度高度相关,随机化后 1 小时(P<0.001)至 5 小时(P<0.001)关联最大,显著关联持续至随机化后 22 小时。
- 血肿扩大风险与随机化后 3 小时(P=0.015)至 8 小时(P=0.002)的收缩压变异度相关。
研究设计与关键结果
- 研究类型为 ATACH-2 试验的事后分析,纳入 961 例脑出血患者,平均年龄 62±13 岁,61.9% 为男性,症状发作至入组平均 184±56 分钟。
- 入组后最初 24 小时平均每小时收缩压变异度为 15.6±16 mm Hg,且随随机化后时间间隔延长显著降低(第 1 小时 41.8±23.3 至第 24 小时 12.4±14.0,P<0.0001)。
- 入组后 5 小时(P=0.014)和 6 小时(P=0.014)的收缩压变异度与 90 天死亡或残疾显著相关,随机化后 8 小时内其余时间点呈正向但未达统计学显著的关联。
- 24 小时内神经功能恶化风险与收缩压变异度高度相关,随机化后 1 小时(P<0.001)至 5 小时(P<0.001)关联最大,显著关联持续至随机化后 22 小时。
- 血肿扩大风险与随机化后 3 小时(P=0.015)至 8 小时(P=0.002)的收缩压变异度相关。
- 收缩压变异度与入组后 72 小时内急性肾损伤风险未见统计学显著关联。
- 校正因素包括年龄、基线格拉斯哥昏迷量表评分、脑室内出血、血肿体积及各时间窗的最大收缩压值。
证据类型、等级与局限
- 证据类型为 ATACH-2 随机对照试验的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为随机化后最初 8 小时内收缩压变异度降低似乎对短期和长期结局影响最大,最初 8 小时可能是未来针对降低收缩压变异度干预的时间窗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Systolic blood pressure (SBP) variability has been associated with an increase in rates of death or disability in patients with intracerebral hemorrhage (ICH). We analyzed data from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 trial to determine whether the association between SBP variability and death or disability at 90 days is dependent on the time from randomization.
METHODS: The difference between maximum and minimum SBP (hourly SBP range) for the first 24 h after enrollment was used to calculate the hourly SBP variability. The effect of hourly SBP variability was evaluated in logistic regression models on: (1) death or disability (modified Rankin scale score of 4-6 at 90 days), (2) hematoma expansion (increase of > 33% in volume on the computed tomography scan obtained at 24 h) within 24 h, (3) neurological deterioration within 24 h, and (4) acute kidney injury within 72 h after enrollment. We adjusted for age, baseline Glasgow Coma Scale score, intraventricular hemorrhage, hematoma volume, and maximum SBP values for each time window.
RESULTS: A total of 961 patients (mean age ± standard deviation [SD], 62 ± 13 years; 61.9% were men) who were enrolled at a mean ± SD time of 184 ± 56 min from symptom onset were analyzed. The mean ± SD hourly SBP variability was 15.6 ± 16 mm Hg. The hourly SBP variability became significantly lower with increasing time intervals from randomization (ranging from 41.8 ± 23.3 at hour 1 to 12.4 ± 14.0 at hour 24, P < 0.0001). SBP variability at five hours (P = 0.014) and six hours (P = 0.014) after enrollment was significantly associated with death or disability at 90 days, with positive but not statistically significant associations observed at all other points up to eight hours after randomization. Risk of neurological deterioration within 24 h was highly associated with SBP variability, with the largest association observed between one (P < 0.001) and five (P < 0.001) hours following randomization, with significant associations observed up to 22 h following randomization. Risk of hematoma expansion was associated with SBP variability between three (P = 0.015) and eight (P = 0.002) hours after randomization. Statistically significant associations between SPB variability and risk of acute kidney injury were not observed.
CONCLUSIONS: Reduced SBP variability within the first eight hours following randomization appears most impactful on both short-term and long-term outcomes in patients with ICH, and the first eight hours may represent a time window for future interventions directed at reducing SBP variability in patients with ICH.
参考来源
- Qureshi AI, Baskett W, Gomes JA, et al. The Association between Hourly Systolic Blood Pressure Variability and Outcomes in Patients with Intracerebral Hemorrhage is Time-Dependent: Post-hoc Analysis of the ATACH-2 Trial. Neurocrit Care. 2025. PMID: 40993486. doi:10.1007/s12028-025-02376-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。